| Andrew Timothy Schmale, MD | |
|
320 N Main St Ste 300, Ann Arbor, MI 48104-1127 | |
| (734) 436-4886 | |
| (734) 436-4878 |
| Full Name | Andrew Timothy Schmale |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 8 Years |
| Location | 320 N Main St Ste 300, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235585829 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 4301500689 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michigan Advanced Psychiatry, P.c. | 2567877574 | 3 |
News Archive
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced that Cancer Research UK's Drug Development Office – the drug development arm of the world's largest independent organization dedicated to cancer research – is standardizing on Phase Forward's InForm™ Global Trial Management solution to support its diverse portfolio of early-stage clinical trials.
pSivida Corp., a leader in the development of tiny, sustained-release drug delivery technologies, with two of the only three ophthalmic sustained-release delivery products approved by the FDA for treatment of back of the eye diseases, announced that its chief executive officer, Dr. Paul Ashton, will discuss ocular drug delivery in diabetic retinopathy during a presentation at the 6th Annual Diabetes Conference in London, on Friday, January 22.
Aradigm Corporation (OTCBB:ARDM) has announced that the European Medicines Agency (EMEA) granted Orphan Drug Designation to the Company's inhaled liposomal ciprofloxacin drug product candidate for the treatment of lung infections associated with cystic fibrosis ("CF").
A randomised trial in this week's issue of THE LANCET shows how a vaccine against human papillomavirus (HPV) infection could potentially reduce the global incidence of cervical cancer.
Having ancestors who were frequently exposed to stressors can improve one's own immune response to stressors, according to Penn State researchers.
› Verified 1 days ago
| Entity Name | Huron Valley Consultation Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750314027 PECOS PAC ID: 5698761161 Enrollment ID: O20040927000324 |
News Archive
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced that Cancer Research UK's Drug Development Office – the drug development arm of the world's largest independent organization dedicated to cancer research – is standardizing on Phase Forward's InForm™ Global Trial Management solution to support its diverse portfolio of early-stage clinical trials.
pSivida Corp., a leader in the development of tiny, sustained-release drug delivery technologies, with two of the only three ophthalmic sustained-release delivery products approved by the FDA for treatment of back of the eye diseases, announced that its chief executive officer, Dr. Paul Ashton, will discuss ocular drug delivery in diabetic retinopathy during a presentation at the 6th Annual Diabetes Conference in London, on Friday, January 22.
Aradigm Corporation (OTCBB:ARDM) has announced that the European Medicines Agency (EMEA) granted Orphan Drug Designation to the Company's inhaled liposomal ciprofloxacin drug product candidate for the treatment of lung infections associated with cystic fibrosis ("CF").
A randomised trial in this week's issue of THE LANCET shows how a vaccine against human papillomavirus (HPV) infection could potentially reduce the global incidence of cervical cancer.
Having ancestors who were frequently exposed to stressors can improve one's own immune response to stressors, according to Penn State researchers.
› Verified 1 days ago
| Entity Name | Michigan Advanced Psychiatry, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629686837 PECOS PAC ID: 2567877574 Enrollment ID: O20210224000966 |
News Archive
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced that Cancer Research UK's Drug Development Office – the drug development arm of the world's largest independent organization dedicated to cancer research – is standardizing on Phase Forward's InForm™ Global Trial Management solution to support its diverse portfolio of early-stage clinical trials.
pSivida Corp., a leader in the development of tiny, sustained-release drug delivery technologies, with two of the only three ophthalmic sustained-release delivery products approved by the FDA for treatment of back of the eye diseases, announced that its chief executive officer, Dr. Paul Ashton, will discuss ocular drug delivery in diabetic retinopathy during a presentation at the 6th Annual Diabetes Conference in London, on Friday, January 22.
Aradigm Corporation (OTCBB:ARDM) has announced that the European Medicines Agency (EMEA) granted Orphan Drug Designation to the Company's inhaled liposomal ciprofloxacin drug product candidate for the treatment of lung infections associated with cystic fibrosis ("CF").
A randomised trial in this week's issue of THE LANCET shows how a vaccine against human papillomavirus (HPV) infection could potentially reduce the global incidence of cervical cancer.
Having ancestors who were frequently exposed to stressors can improve one's own immune response to stressors, according to Penn State researchers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Timothy Schmale, MD 320 N Main St Ste 300, Ann Arbor, MI 48104-1127 Ph: (734) 436-4886 | Andrew Timothy Schmale, MD 320 N Main St Ste 300, Ann Arbor, MI 48104-1127 Ph: (734) 436-4886 |
News Archive
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced that Cancer Research UK's Drug Development Office – the drug development arm of the world's largest independent organization dedicated to cancer research – is standardizing on Phase Forward's InForm™ Global Trial Management solution to support its diverse portfolio of early-stage clinical trials.
pSivida Corp., a leader in the development of tiny, sustained-release drug delivery technologies, with two of the only three ophthalmic sustained-release delivery products approved by the FDA for treatment of back of the eye diseases, announced that its chief executive officer, Dr. Paul Ashton, will discuss ocular drug delivery in diabetic retinopathy during a presentation at the 6th Annual Diabetes Conference in London, on Friday, January 22.
Aradigm Corporation (OTCBB:ARDM) has announced that the European Medicines Agency (EMEA) granted Orphan Drug Designation to the Company's inhaled liposomal ciprofloxacin drug product candidate for the treatment of lung infections associated with cystic fibrosis ("CF").
A randomised trial in this week's issue of THE LANCET shows how a vaccine against human papillomavirus (HPV) infection could potentially reduce the global incidence of cervical cancer.
Having ancestors who were frequently exposed to stressors can improve one's own immune response to stressors, according to Penn State researchers.
› Verified 1 days ago
Ernesto F Figueroa, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2020 Hogback Road, Suite 19, Ann Arbor, MI 48105 Phone: 734-677-5900 | |
Dushyant G. Trivedi, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 555 William St., Suite #24c, Ann Arbor, MI 48104 Phone: 734-994-1171 Fax: 734-712-5745 | |
Dr. Edwin Seymour Tobes, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 117 N 1st St, Suite 103, Ann Arbor, MI 48104 Phone: 734-649-4623 | |
Dr. Joyce Danielski Kales, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Rd, Ann Arbor, MI 48105 Phone: 734-769-7100 Fax: 734-769-7091 | |
Dr. Louis William Feurino Iii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 900 Victors Way 240, Ann Arbor, MI 48108 Phone: 313-605-5330 Fax: 734-661-0322 | |
Benjamin Martin Bly, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Drive, 1st Floor University Hospital Room 1b300, Ann Arbor, MI 48109 Phone: 734-936-9035 Fax: 734-936-5520 | |
Hao Cheng, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 425-502-5290 |